Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Article
Reijneveld, Jaap C., Taphoorn, Martin J. B., Coens, Corneel, Bromberg, Jacoline E. C., Mason, Warren P., Hoang-Xuan, Khê, Ryan, Gail, Hassel, Mohamed Ben, Enting, Roelien H., Brandes, Alba A., Wick, Antje, Chinot, Olivier, Reni, Michele, Kantor, Guy, Thiessen, Brian, Klein, Martin, Verger, Eugenie, Borchers, Christian, Hau, Peter, Back, Michael, Smits, Anja, Golfinopoulos, Vassilis, Gorlia, Thierry, Bottomley, Andrew, Stupp, Roger and Baumert, Brigitta G. (2016) Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. The Lancet Oncology 17 (11), pp. 1533-1542.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | The Lancet Oncology | ||||
| Publisher | Elsevier | ||||
| Place of Publication | NEW YORK | ||||
| Volume | 17 | ||||
| Number of Issue or Book Chapter | 11 | ||||
| Page Range | pp. 1533-1542 | ||||
| Date | 2016 | ||||
| Date of publication | 17 Mar 2020 12:06 | ||||
| Institutions | Medicine > Lehrstuhl für Neurologie | ||||
| Identification Number |
| ||||
| Keywords | BRAIN CANCER-PATIENTS; MINI-MENTAL-STATE; TERM-FOLLOW-UP; EUROPEAN-ORGANIZATION; RADIATION-THERAPY; ANAPLASTIC OLIGODENDROGLIOMA; TEMOZOLOMIDE CHEMOTHERAPY; CLINICAL-TRIALS; ADULT PATIENTS; DOSE-RESPONSE; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 42840 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric